UK: Lower prices for LNG EC

December 2025. ECEC and the International Planned Parenthood Federation (IPPF) have come together to merge their data on mifepristone for medical abortion and ulipristal acetate (UPA) for emergency contraception, with the aim of shedding light on the actual global availability of these essential medicines. A summary of this joint analysis has now been published in…
The Italian Medical Contraception Society (SMIC) is requesting to the Ministry of Health and the national Medicines Agency that EC pills are mandatorily stocked in all pharmacies, in order to make them more accessible and reduce time to start of treatment; and that EC is covered by the national health system, and thus provided free of charged in, at…
In February 2015, the Portuguese Society of Contraception launched a practical EC guide for pharmacists. After Portugal decided to follow the European Union Commission recommendation to make UPA EC accessible directly from pharmacies without prescription, UPA EC is expected to be available directly from pharmacists in the country in the next few months. The Portuguese…

February 2024. The European Parliamentary Forum for Sexual & Reproductive Rights (EPF) presented the 2024 edition of the Europe Contraception Atlas. ECEC was honored to participate in the launch event, bringing attention to persisting gaps in access to emergency contraception in Europe. Read more about the launch event here and retrieve the recording here….
October 2025 — Last September, the World Health Organization (WHO) published the 24th Model List of Essential Medicines (EML). Levonorgestrel (LNG) emergency contraceptive pills (ECPs) have been included in the EML since 1999, and ulipristal acetate (UPA) ECPs since 2017, underscoring their continued importance in ensuring access to safe and effective reproductive health options. Essential…
March, 2022. An urgent Call to Action has been issued by over 60 global and national organizations from Hungary, Moldova, Poland, Romania, Slovakia and Ukraine, calling on decision makers in Europe and internationally, to act swiftly to protect the human rights and address the sexual and reproductive health needs of women and girls and marginalized…
Menú